ONCO3.SA- Oncoclínicas do Brasil Serviços Médicos S.A.
🇧🇷 BRLHealthcare · Medical Care Facilities
Price & Performance
Performance
Analysis & Verdict
Analyst Ratings
Wall Street consensus from 3 analysts
12-Month Price Target
$1.90
Based on analyst estimates; price targets are opinions, not guarantees.
Fair Value Estimates
Current price: $1.01
Graham Number
√(22.5 × EPS × Book Value)
N/A
Benjamin Graham's intrinsic value formula. Assumes a fair stock trades at no more than 22.5× the product of EPS and book value per share.
Bazin Ceiling Price
Avg. Annual DPS (5Y) ÷ 6%
N/A
Décio Bazin's dividend-based ceiling. The max price you should pay so that dividends alone deliver at least 6% annual yield on your cost basis.
These are simplified estimates. Not financial advice.
Buy & Hold Checklist
Quality criteria for long-term holding
1/10
14% score
Pays dividends
No dividend history found
Dividend consistency (5Y+)
Uninterrupted dividend payments for at least 5 years
ROE above 10%
-273.5%Return on equity - measures how efficiently capital is used
Positive profit margin
-84.8%Net profit margin must be positive - company earns more than it spends
Revenue growth (annual)
-28.5%Annual revenue must be growing compared to the prior year
Earnings growth (annual)
Annual earnings must be growing compared to the prior year
Debt/Equity below 2×
3949.01×Low financial leverage reduces risk of distress
Current ratio above 1
0.44×Short-term assets must cover short-term liabilities
Daily liquidity above $5M
$21M/dayHigh trading volume ensures easy entry and exit
Dividend yield above 0%
Stock must distribute income to shareholders
Financials
Revenue & Results
Key Statistics
Earnings
EPS (TTM)
$-5.13
P/E (TTM)
-
Fwd P/E
12.8
Dividends & Income
Dividends
This stock does not pay dividends.
Tools & Simulators
ONCO3.SA vs Peers, Indexes & Commodities
?Click a card below to plot it on the chart
Loading history…
Parameters
Final value
R$ 552.068,46
Total invested
R$ 130.000,00
Total interest
R$ 422.068,46
Balance over time
Period breakdown
| Period | Balance | Invested | Interest |
|---|---|---|---|
| Start | R$ 10.000,00 | R$ 10.000,00 | R$ 0,00 |
| Year 1 | R$ 17.523,25 | R$ 16.000,00 | R$ 1.523,25 |
| Year 2 | R$ 25.949,29 | R$ 22.000,00 | R$ 3.949,29 |
| Year 3 | R$ 35.386,45 | R$ 28.000,00 | R$ 7.386,45 |
| Year 4 | R$ 45.956,07 | R$ 34.000,00 | R$ 11.956,07 |
| Year 5 | R$ 57.794,05 | R$ 40.000,00 | R$ 17.794,05 |
| Year 6 | R$ 71.052,59 | R$ 46.000,00 | R$ 25.052,59 |
| Year 7 | R$ 85.902,15 | R$ 52.000,00 | R$ 33.902,15 |
| Year 8 | R$ 102.533,65 | R$ 58.000,00 | R$ 44.533,65 |
| Year 9 | R$ 121.160,94 | R$ 64.000,00 | R$ 57.160,94 |
| Year 10 | R$ 142.023,50 | R$ 70.000,00 | R$ 72.023,50 |
| Year 11 | R$ 165.389,57 | R$ 76.000,00 | R$ 89.389,57 |
| Year 12 | R$ 191.559,57 | R$ 82.000,00 | R$ 109.559,57 |
| Year 13 | R$ 220.869,97 | R$ 88.000,00 | R$ 132.869,97 |
| Year 14 | R$ 253.697,61 | R$ 94.000,00 | R$ 159.697,61 |
| Year 15 | R$ 290.464,57 | R$ 100.000,00 | R$ 190.464,57 |
| Year 16 | R$ 331.643,57 | R$ 106.000,00 | R$ 225.643,57 |
| Year 17 | R$ 377.764,05 | R$ 112.000,00 | R$ 265.764,05 |
| Year 18 | R$ 429.418,98 | R$ 118.000,00 | R$ 311.418,98 |
| Year 19 | R$ 487.272,51 | R$ 124.000,00 | R$ 363.272,51 |
| Year 20 | R$ 552.068,46 | R$ 130.000,00 | R$ 422.068,46 |
What is compound interest?
Compound interest means that the interest you earn in one period is added to your principal, so in the next period you earn interest on a larger base. This creates exponential growth: the longer your time horizon, the more dramatic the effect.
Which rate should I use?
The Ibovespa, Brazil's main stock index, has historically returned roughly 12%/year in nominal terms over long periods. The CDI, the interbank interest benchmark, sits around 11% and tracks the Selic rate. The poupança (savings) pays about 6%, while inflation (IPCA) has run near 5%. Nominal Brazilian returns look high next to US figures mainly because inflation is higher, so compare real (inflation-adjusted) returns when planning.
Formula used
FV = PV × (1+r)^n + PMT × ((1+r)^n − 1) / rwhere r is the monthly rate, n is the number of months, PV is the initial investment, and PMT is the monthly contribution. Annual rates are converted to monthly viar = (1 + annual%)^(1/12) − 1.
For educational purposes only. Not financial advice. Past returns do not guarantee future results.
Get the weekly market breakdown
Real numbers, plain English, no hype. The stories and data that actually move stocks and crypto, straight to your inbox.
Subscribe freeDiscussion
Sign in to join the discussionSign inLoading…
Discover
Related Assets
Healthcare
Related Articles
About Oncoclínicas do Brasil Serviços Médicos S.A.
Oncoclínicas do Brasil Serviços Médicos S.A., together with its subsidiaries, provides oncology, hematology, radiotherapy, and genomics healthcare services in Latin America. The company offers treatment services, including radiotherapy, hormone therapy, immunotherapy, port-a-cath, palliative care, target therapy, breast cancer hormone therapy, bone marrow transplant, non-oncological infusions, oral chemotherapy, and prostate cancer hormone therapy; and surgery procedures, such as breast, head and neck, lung, prostate cancer, stomach, bladder cancer, oncological, kidney cancer, gynecological, and testicular cancer. It also provides diagnostics services comprising pathological analysis, genetic testing, molecular journey, personalized medicine and individualized treatment, myelogram-bone marrow biopsy, and ONCO test-PDO. In addition, the company offers treatment support services, which include veinviewer, cryotherapy, integrative medicine, and DeLife, as well as hilotherapy, laser therapy, OC care line, OC precision medicine, OncoACCESS, survivorship, and telemedicine services. Oncoclínicas do Brasil Serviços Médicos S.A. was incorporated in 2010 and is headquartered in São Paulo, Brazil.
Sector
Healthcare
Industry
Medical Care Facilities
Location
São Paulo, Brazil
CEO
Mr. Carlos Gil Moreira Ferreira
Stock Market ROI Pro
All features, zero ads- web & app
Unlock every feature, ad-free, across our website and iOS app.
Oncoclínicas do Brasil Serviços Médicos S.A. (ONCO3.SA) stock trades at $1.01. With a market capitalization of $1.14 billion, ONCO3.SA is a small-cap healthcare stock. It trades at a forward P/E of 12.8 and earnings per share (EPS) of $-5.13. Over the most recent period the company reported a 28% year-over-year revenue decline and a net profit margin of -84.8%. Below you'll find ONCO3.SA's full fundamentals, fair-value estimates, dividend history, earnings and our buy, hold or avoid verdict for 2026.
ONCO3.SA - Frequently Asked Questions
Is Oncoclínicas do Brasil Serviços Médicos S.A. (ONCO3.SA) a good stock to buy in 2026?
Oncoclínicas do Brasil Serviços Médicos S.A. (ONCO3.SA) shows risks such as declining revenue (-28%), negative profit margins and high leverage (debt/equity of 3949.0). Whether ONCO3.SA is a good buy in 2026 depends on your time horizon and risk tolerance - review the full bull case, bear case and fair-value estimates above. This is informational analysis, not financial advice.
What is ONCO3.SA's stock price today?
Oncoclínicas do Brasil Serviços Médicos S.A. (ONCO3.SA) trades at $1.01 as of October 2, 2026. Prices on this page update throughout the trading day.
Does ONCO3.SA pay a dividend?
No. Oncoclínicas do Brasil Serviços Médicos S.A. (ONCO3.SA) does not currently pay a dividend, so the return comes entirely from share-price appreciation.
What is ONCO3.SA's market cap?
Oncoclínicas do Brasil Serviços Médicos S.A. (ONCO3.SA) has a market capitalization of $1.14 billion, classifying it as a small-cap stock in the Healthcare sector.
Disclaimer: This page - including any buy/hold/avoid view, fair value or price estimate - is generated from market data for informational and educational purposes only and does not constitute financial, investment or trading advice. Data may be delayed or inaccurate. Always do your own research and consult a licensed financial advisor before making any investment decision.